Maximum home blood pressure: a novel indicator of target-organ damage in hypertension  Blood pressure variability has recently been shown to be a strong.

Slides:

Advertisements

Similar presentations

Treatment-Resistant Hypertension: Magnitude of the Problem Power Over Pressure

Advertisements

Hypertension. Hypertension or high blood pressure is a chronic medical condition in which the blood pressure in the arteries is elevated. This requires.

Valsartan Antihypertensive Long-Term Use Evaluation Results

The INSIGHT study - Reliable blood pressure control and additional benefits for hypertensive patients Anthony M Heagerty Department of Medicine Manchester.

TROPHY TRial Of Preventing HYpertension. High-normal BP increases CV risk Vasan RS et al. N Engl J Med. 2001;345: Incidence of CV events in women.

Overcoming the challenge of blood pressure control in prediabetic and diabetic patients: PICASSO T2D Study Efficacy and tolerability of fixed dose combination.

“ Age-Related Differences in Characteristics, Performance Measures, Treatment Trends, and Outcomes in Patients with Ischemic Stroke ” Gregg C. Fonarow,

Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.

Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.

HYPERTENSION The Alabama Department of Public Health’s Hypertension Program.

William B. Kannel, MD, FACC Former Director, Framingham Heart Study

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.

Ambulatory blood pressure as a predictor of cardiovascular risk: What’s new?

Systolic hypertension not an isolated problem Michael Weber, MD Professor of Medicine Associate Dean Downstate College of Medicine State University of.

CARDIOVASCULAR CARE of the OUTPATIENT Diane M. Enzweiler, MSN, ANP-BC St. Elizabeth Physicians: Heart and Vascular.

Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.

Cardiovascular Effects of Endurance Exercise- Good or Bad? Catherine Moltzan MD FRCPC.

The TRial Of Preventing HYpertension (TROPHY) TROPHY.

Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,

1 Current & New treatment strategies to address CV Risk.

Copyleft Clinical Trial Results. You Must Redistribute Slides HYVET Trial The Hypertension in the Very Elderly Trial (HYVET)

To assess the prognostic value of variability in home-measured blood pressure (BP) and heart rate (HR) in a general population. Objective: Methods: BP.

How can you estimate simply the cardiovascular risk of your patients?

Blood Pressure Analysis among Sedentary and Moderately Active College Males Research Performed By Joseph Luncford Environmental Biology Tennessee Technological.

Central blood pressure: what do we really know today?

A Controlled Trial of Renal Denervation for Resistant Hypertension

CARDIAC DIMENSIONS ARE LARGELY DETERMINED BY DIETARY SALT IN PATIENTS WITH PRIMARY ALDOSTERONISM. RESULTS OF A CASE CONTROL STUDY Endocrine Hypertension.

Objective: To asses the efficacy of hydrochlorothiazide on 24-h blood pressure (BP) control.Methods: Review of all the randomized trials that assessed.

Guidelines recommend, as first-line treatment for hypertension, a diuretic or the combination of diuretic ± ACE inhibitor. Prevention of Stroke in Patients.

Short Sleep Duration as a Predictor of Cardiovascular Events Summary and Comment by Jamaluddin Moloo, MD, MPH Published in Journal Watch General Medicine.

Canagliflozin Cardiovascular Safety. 2 Potential CV protection pathways of SGLT2i Diab Vasc Dis Res Mar;12(2):

Blood pressure control: Where do we stand? Latest data from Italy Tocci G et al. J Hypertens. 2012;30:

The Evaluate Trial. Rationale and Design of the Eplerenone Combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment.

The MICRO-HOPE. Microalbuminuria, Cardiovascular and Renal Outcomes in the Heart Outcomes Prevention Evaluation Reference Heart Outcomes Prevention Evaluation.

Are the European Practice Guidelines for the Management of Arterial Hypertension (2007) adapted to the old and the frail? Anette Hylen

Impact of Heart Rate on Central Aortic Pressures and Hemodynamics Analysis From the CAFE (Conduit Artery Function Evaluation) Study : CAFE-Heart Rate Bryan.

Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Exercise and Weight Loss Reduce Blood Pressure in.

Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,

From: Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study Ann Intern Med. 2015;163(5):

Dr John Cox Diabetes in Primary Care Conference Cork

The Significance of Albuminuria

Plots of clinic blood pressure (CBP) versus daytime ambulatory (ABP) and home bl.. Figure 1. Plots of clinic blood pressure (CBP) versus daytime ambulatory.

Orthostatic Hypertension: Impact on Cardiovascular Risk

Objectives Describe the cardiovascular monitoring techniques used in the care of critically ill patients and how to interpret the results of hemodynamic.

White-coat Hypertension

Copyright © 2007 American Medical Association. All rights reserved.

United States Preventive Services Task Force: Recommendations for ABPM

Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.

PS Sever, PM Rothwell, SC Howard, JE Dobson, B Dahlöf,

Subclinical organ damage Treatment LVH

UOG Journal Club: July 2012 Maternal hemodynamics at 11–13 weeks’ gestation and risk of pre-eclampsia A. Khalil, R. Akolekar, A. Syngelaki, M. Elkhouli.

The Hypertension in the Very Elderly Trial (HYVET)

Relative risk of major events with atenolol vs placebo

Volume 13, Issue 4, Pages (April 2014)

Lowering of SBP by 20 mm Hg Reduces Cardiovascular Risk by Half

Primary end point in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up) Primary end point Nifedipine Placebo.

Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.

CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so.

Relative risks of clinical events for primary and secondary prevention with selected drugs Thomas A Gaziano, et al. Lancet 2006; 368:

Characteristics of Study Subjects and Events, According to the Quintile of Exposure to Fine Particulate Matter (PM2.5)* - Part I Kristin A. Miller et al.

Baseline Characteristics of the Subjects*

DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.

Entry, Randomization, and Follow-up of Patients in the Hypertension in the Very Elderly Trial Of the 461 patients who did not meet the protocol criteria,

Demographic and Clinical Characteristics (means ± SD or %) of Subjects in Different Office SBP and DBP Categories Mancia G et al Hypertension. 2005;45:1072.

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

Mean pulmonary arterial systolic pressure (PASP) with 95% CI error bars and individual data points at rest breathing room air (baseline), during 20 min.

End point Valsartan Valsartan+HCTZ p

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.

Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.

Presentation transcript:

Maximum home blood pressure: a novel indicator of target-organ damage in hypertension  Blood pressure variability has recently been shown to be a strong predictor of stroke and cardiovascular events, independently of the mean systolic blood pressure level. 1  The clinical implication of variability in blood pressure, as measured by home blood pressure monitoring, has never been reported.  A new study has investigated the association between maximum home blood pressure and target-organ damage in 356 never-treated hypertensive subjects. 1. Rothwell PM et al. Lancet. 2010;375: Matsui Y et al. Hypertens, 2011;57: in press

Maximum home systolic blood pressure measurements were observed up to 50 times per day Number of episodes per/day Matsui Y et al. Hypertens. 2011;57: in press

High incidence of maximum home systolic blood pressure is associated with a high degree of cardiac and vascular remodeling Matsui Y et al. Hypertens. 2011;57: in press

Conclusion This study provides additional information on the importance of blood pressure stabilization to prevent cardiovascular complication in hypertensive patients:  Transiently high blood pressure readings at home should be taken seriously as meaningful indicators for hypertensive damage in the heart and artery. 1  The variability in systolic blood pressure can be simply assessed by home blood pressure measurements. 1  This study confirms, that effective antihypertensive treatment should not only reduce, but also stabilize blood pressure Matsui Y et al. Hypertens. 2011;57: in press; 2.Rothwell PM. et al. Lancet. 2010;375: